WEM AND PREES MEDICAL PRACTICE — All Prescriptions & Medications
Practice Code: M82035 | SHREWSBURY, SY4 5AF
Over the last 12 months, WEM AND PREES MEDICAL PRACTICE prescribed 300,951 items across 704 different medications at a total cost of £2,372,707 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Balsalazide sodium | 10 | 1,300 | £270 | -32.9% ▼ |
| Sennosides | 10 | 3,600 | £70 | -67.6% ▼ |
| Paliperidone | 10 | 10 | £2.5K | -34.2% ▼ |
| Valaciclovir | 10 | 600 | £1.2K | -28.8% ▼ |
| Other compound vitamin/mineral formulation preparations | 10 | 344 | £24 | -68.8% ▼ |
| Nabumetone | 10 | 280 | £89 | -28.1% ▼ |
| Ciprofloxacin | 10 | 70 | £61 | +25.8% ▲ |
| Levobunolol hydrochloride | 10 | 600 | £177 | +37.7% ▲ |
| Light liquid paraffin | 10 | 4,000 | £77 | -70.6% ▼ |
| Imiquimod | 10 | 224 | £784 | +40.7% ▲ |
| 10 | 126 | £38 | -66.5% ▼ | |
| 10 | 100 | £39 | +3.5% ▲ | |
| 10 | 300 | £169 | -55.2% ▼ | |
| Glycopyrronium bromide | 11 | 3,320 | £4.1K | -46.4% ▼ |
| Co-tenidone (Atenolol/chlortalidone) | 11 | 308 | £61 | -47.3% ▼ |
| Valsartan/amlodipine | 11 | 308 | £210 | +0.3% vs avg |
| Enoxaparin | 11 | 305 | £3.0K | -46.3% ▼ |
| Erdosteine | 11 | 220 | £52 | +14.6% ▲ |
| Haloperidol | 11 | 402 | £1.8K | -76.9% ▼ |
| Opicapone | 11 | 330 | £583 | -42.5% ▼ |
| Riluzole | 11 | 616 | £3.4K | +6.0% ▲ |
| Disulfiram | 11 | 275 | £945 | -25.7% ▼ |
| Erythromycin ethylsuccinate | 11 | 1,176 | £140 | -52.9% ▼ |
| Iron and folic acid | 11 | 330 | £28 | +38.8% ▲ |
| Sodium fluoride | 11 | 585 | £65 | -66.8% ▼ |
| Other health supplement preparations | 11 | 5,460 | £86 | -76.8% ▼ |
| Ready to serve 50% MCT liquid (0913181) | 11 | 11.0K | £600 | +62.0% ▲ |
| Ketotifen fumarate | 11 | 150 | £146 | +18.2% ▲ |
| Timolol and brimonidine | 11 | 55 | £138 | -21.6% ▼ |
| Dexamethasone sodium metasulphobenzoate | 11 | 88 | £78 | +48.0% ▲ |
| Clindamycin/tretinoin | 11 | 510 | £191 | -6.3% ▼ |
| 11 | 28 | £265 | -7.6% ▼ | |
| 11 | 24 | £332 | +43.8% ▲ | |
| 11 | 23 | £1.7K | +33.6% ▲ | |
| 11 | 43 | £88 | +19.5% ▲ | |
| 11 | 990 | £3.1K | -0.3% vs avg | |
| 11 | 2,420 | £97 | +22.3% ▲ | |
| 11 | 1,800 | £587 | +103.9% ▲ | |
| 11 | 990 | £3.3K | +75.4% ▲ | |
| 11 | 110 | £539 | -21.4% ▼ | |
| 11 | 310 | £1.4K | -7.1% ▼ | |
| 11 | 200 | £871 | +37.3% ▲ | |
| Naftidrofuryl oxalate | 12 | 1,344 | £160 | -63.2% ▼ |
| Codeine phosphate | 12 | 4,000 | £93 | -16.4% ▼ |
| Almotriptan | 12 | 81 | £186 | -3.2% ▼ |
| Linagliptin/metformin | 12 | 672 | £355 | -64.4% ▼ |
| Testosterone enantate | 12 | 576 | £18.6K | +68.0% ▲ |
| Indoramin | 12 | 324 | £260 | -21.1% ▼ |
| Hydroxycarbamide | 12 | 432 | £60 | -58.4% ▼ |
| Ascorbic acid | 12 | 319 | £449 | -41.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.